| Not Yet Recruiting | Apremilast and Adalimumab in Psoriatic Arthritis Patients NCT07398651 | Tanta University | N/A |
| Not Yet Recruiting | Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) NCT07486960 | Merck Sharp & Dohme LLC | Phase 2 |
| Not Yet Recruiting | A Phase II Clinical Trial to Evaluate the Efficacy and Safety of TQH3906 Capsules in the Treatment of Active P NCT07406035 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis NCT07286058 | Takeda | Phase 3 |
| Not Yet Recruiting | Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis NCT07403890 | NHS Greater Glasgow and Clyde | N/A |
| Not Yet Recruiting | Combined High-Intensity Aerobic Training and Resistance Training in Psoriatic Arthritis NCT07352696 | Vastra Gotaland Region | N/A |
| Not Yet Recruiting | Skin Autofluorescence Assessment of Advanced Glycation End Products in Rheumatic Diseases NCT07329556 | Bursa City Hospital | — |
| Recruiting | A Study of Picankibart in Patients With Active Psoriatic Arthritis NCT07295509 | Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. | Phase 2 / Phase 3 |
| Recruiting | A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over T NCT07290036 | UCB Biopharma SRL | Phase 1 |
| Recruiting | Creating Health Course Study for People With Rheumatological Conditions NCT07180537 | Terry L. Wahls | N/A |
| Recruiting | A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With NCT06888193 | UCB Biopharma SRL | Phase 1 |
| Completed | Activating the Cholinergic Anti-Inflammatory Pathway in Healthy Volunteers and People With Inflammatory Arthri NCT06555562 | Surf Therapeutics | N/A |
| Recruiting | A Study of SPY072 in Rheumatic Disease NCT07148414 | Spyre Therapeutics, Inc. | Phase 2 |
| Recruiting | Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms NCT06786936 | NHS Greater Glasgow and Clyde | — |
| Recruiting | Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy NCT06586281 | University of California, San Diego | N/A |
| Recruiting | Genetic Variation in TRAF3IP2 (rs13190932) NCT07086924 | South Valley University | N/A |
| Active Not Recruiting | A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi NCT06714461 | Sanofi | — |
| Recruiting | Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis NCT06865105 | AbbVie | Phase 2 |
| Recruiting | A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medi NCT06671496 | Takeda | Phase 3 |
| Recruiting | A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Ac NCT06864026 | Eli Lilly and Company | Phase 4 |
| Recruiting | Card14gene (rs34367357 ) Polymorphism in Egyptian Psoriatic and Psoriatic Arthritis Patient NCT06870500 | South Valley University | N/A |
| Recruiting | A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines NCT06671483 | Takeda | Phase 3 |
| Recruiting | An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthriti NCT06764693 | AbbVie | — |
| Not Yet Recruiting | Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real) NCT06802848 | Chongqing Genrix Biopharmaceutical Co., Ltd | — |
| Recruiting | Modifying PEST for Psoriatic Arthritis Screening NCT06382051 | Novartis Pharmaceuticals | N/A |
| Not Yet Recruiting | Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Informatio NCT06790940 | Shanghai Yueyang Integrated Medicine Hospital | — |
| Completed | Artificial Intelligence Literacy and E-Health Literacy in Rheumatic Diseases NCT07054749 | Gulseren Demir Karakilic | — |
| Enrolling By Invitation | Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases NCT06763783 | Region Skane | Phase 4 |
| Recruiting | A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic NCT06454188 | CARE ARTHRITIS LTD. | Phase 4 |
| Completed | IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis Patients NCT06729463 | South Valley University | N/A |
| Recruiting | A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis NCT06640257 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 3 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic A NCT06624228 | UCB Biopharma SRL | Phase 3 |
| Active Not Recruiting | Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overw NCT06588296 | Eli Lilly and Company | Phase 3 |
| Recruiting | INSELMA - a Randomised Controlled Trial NCT06583980 | The Danish Center for Expertise in Rheumatology | N/A |
| Completed | Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease NCT06568029 | Karolinska Institutet | — |
| Recruiting | A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderat NCT06506916 | UCB Biopharma SRL | Phase 3 |
| Recruiting | Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy NCT06544343 | University Of Perugia | N/A |
| Not Yet Recruiting | The Effect of Psoriatic Arthritis on Female Sexual Dysfunction NCT06370221 | Egymedicalpedia | — |
| Not Yet Recruiting | PsA Digital Phenotyping and Inflammation Drivers Study NCT06347237 | Jolanda Luime | — |
| Active Not Recruiting | Improving Virtual Care of Arthritis: Integrating a Smartphone App Into the EHR for Improved Timeliness of Visi NCT06004700 | Brigham and Women's Hospital | N/A |
| Completed | Assessment of Fatigue in Psoriatic Arthritis and Cutaneous Psoriasis Patients NCT06101706 | Centre Hospitalier Henri Duffaut - Avignon | N/A |
| Recruiting | Rheumatology Diet Study NCT06339957 | University of Central Florida | — |
| Recruiting | WORK-ON Vocational Rehabilitation for People with Inflammatory Arthritis NCT06299917 | The Danish Center for Expertise in Rheumatology | N/A |
| Recruiting | Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis NCT06176508 | Hansoh BioMedical R&D Company | Phase 2 |
| Unknown | Effect of Silymarin Against Methotrexate-induced Liver Injury in Rheumatic Diseases NCT06277635 | Phramongkutklao College of Medicine and Hospital | N/A |
| Completed | A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris NCT06191042 | selectION Therapeutics GmbH | Phase 1 |
| Enrolling By Invitation | Mat Pilates Exercise Program in Patients With Axial Psoriatic Arthritis NCT06176586 | Izmir Katip Celebi University | N/A |
| Completed | Upadacitinib Versus IL-17 Inhibitors in Patients With Psoriatic Arthritis NCT07386717 | Peking University First Hospital | — |
| Recruiting | Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Disea NCT04924270 | Odense University Hospital | Phase 2 |
| Not Yet Recruiting | Response to Upadacitinib of Enthesitis Evaluated by Ultrasound in Patients With Psoriatic Arthritis NCT06144567 | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | — |
| Not Yet Recruiting | Cohort Project of Patients With Inflammatory Rheumatism NCT06059430 | Centre Hospitalier Universitaire de Nice | — |
| Recruiting | Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) NCT06730334 | Nanjing Medical University | — |
| Recruiting | Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients NCT05669833 | University of Pennsylvania | Phase 3 |
| Completed | A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psor NCT05855967 | Eli Lilly and Company | Phase 4 |
| Recruiting | HIPPOCRATES Prospective Observational Study NCT05858528 | University of Oxford | — |
| Recruiting | Evaluation of Sarcopenia and Related Factors in Patients Diagnosed With Psoriatic Arthritis NCT06437392 | Ankara City Hospital Bilkent | — |
| Active Not Recruiting | Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis NCT05908240 | University of Pennsylvania | N/A |
| Unknown | Impact of Air Pollution on the Course of Inflammatory Rheumatism NCT05862584 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | Hand Exercises in Psoriatic Arthritis NCT06263634 | Akdeniz University | N/A |
| Completed | RAFTLIN-1 Levels in Axial Spondyloarthritis and Psoriatic Arthritis NCT05771389 | Bezmialem Vakif University | N/A |
| Completed | Use of Telemedicine to Address 'Off Target' Symptoms in Psoriatic Arthritis (PsA) NCT05631223 | University of Pennsylvania | N/A |
| Active Not Recruiting | Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity NCT05715463 | Brigham and Women's Hospital | N/A |
| Completed | Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease NCT05424926 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | The Effect of Brief Versus Individually Tailored Dietary Advice on Change in Lipids, Blood Pressure, and Diet NCT05772325 | Diakonhjemmet Hospital | N/A |
| Terminated | VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA) NCT05715125 | Ventyx Biosciences, Inc | Phase 2 |
| Unknown | Clinical and Molecular Characterization of Axial Psoriatic Arthritis (PsA), A Pilot Study NCT05925842 | Group for Research and Assessment of Psoriasis and Psoriatic Arthritis | — |
| Recruiting | Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis NCT05954364 | Women's College Hospital | — |
| Completed | Validation of Handheld Ultrasound Devices in Rheumatology NCT06580886 | Ottawa Hospital Research Institute | — |
| Active Not Recruiting | A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps NCT05866614 | Celltrion | — |
| Completed | The Evaluation of Injection Site Pain and Adherence in Patients Switching From a Low To High Concentration Ada NCT05913817 | Jamp Pharma Corporation | — |
| Unknown | Monocyte Chemoattractant Protein-1 in Psoriatic Arthritis Patients NCT05637905 | Assiut University | — |
| Active Not Recruiting | An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given NCT05616871 | AbbVie | — |
| Unknown | SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a B NCT05598684 | Fresenius Kabi, France | — |
| Terminated | Psoriatic Arthritis Study of Izokibep NCT05623345 | ACELYRIN Inc. | Phase 2 / Phase 3 |
| Completed | Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Data NCT06172426 | Novartis Pharmaceuticals | — |
| Unknown | FAPI-PET/CT in Psoriatic Arthritis NCT05686876 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Completed | Treatment Persistence of Biologics in Patients with PsA in Japan; Retrospective Cohort Study Using a Claims Da NCT06600009 | Novartis | — |
| Terminated | Quantitative Ultrasound of the Enthesis in Fibromyalgia and Psoriatic Arthritis NCT05447741 | Centre hospitalier de l'Université de Montréal (CHUM) | — |
| Recruiting | Cytokine Expression in Psoriasis Patients with and Without Joint Involvement NCT05307809 | Poitiers University Hospital | N/A |
| Completed | A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi® NCT05332730 | Bio-Thera Solutions | Phase 1 |
| Completed | Role of Intermittent Fasting in Psoriasis and Psoriatic Arthritis NCT05590247 | Ohio State University | N/A |
| Terminated | Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis NCT05511519 | Aclaris Therapeutics, Inc. | Phase 2 |
| Active Not Recruiting | Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis NCT04991116 | Sun Pharmaceutical Industries Limited | Phase 3 |
| Completed | Monitoring of Inflammatory Conditions NCT05458531 | University of Nottingham | — |
| Unknown | The Effects of Jing Si Herbal Tea Liquid Packets on Fatigue in Patients With Inflammatory Arthritis NCT05257174 | Buddhist Tzu Chi General Hospital | N/A |
| Unknown | Yuflyma® (Adalimumab), Patient Experience After Switching NCT05427942 | Celltrion HealthCare France | — |
| Terminated | Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis NCT04269993 | Brown University | Phase 2 |
| Unknown | Accelerometry in Follow up of Arthritis - a Pilot Study NCT05301621 | Helse Forde | — |
| Unknown | bIosimilar of aDalimumab, an European evAluation NCT05190484 | Fresenius Kabi | — |
| Recruiting | Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidat NCT04751396 | M.D. Anderson Cancer Center | — |
| Unknown | Ticopa Serum Analysis: an Analysis of Blood Samples From the TICOPA Study NCT05329896 | University of Leeds | — |
| Completed | 2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treat NCT05155098 | Novartis Pharmaceuticals | — |
| Recruiting | Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic Arthritis NCT05291819 | Diakonhjemmet Hospital | N/A |
| Recruiting | Stronger Together Psoriatic Arthritis Wellness Study NCT05652608 | Global Healthy Living Foundation | — |
| Completed | Medication Adherence in Psoriatic Arthritis NCT05223062 | Bezmialem Vakif University | — |
| Completed | Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, Ps NCT05215561 | Novartis Pharmaceuticals | — |
| Unknown | Survey About Diet in Chronic Inflammatory Rheumatic Diseases NCT05283096 | Poitiers University Hospital | — |
| Completed | Small Changes Behavioural Weight Loss Treatment Approach for Psoriatic Arthritis Patients With Comorbid Obesit NCT05225623 | University of Calgary | Phase 1 |
| Completed | The Effects of Weight Loss on Psoriatic Arthritis NCT05393141 | Hacettepe University | N/A |
| Completed | Neuropathic Pain in Psoriatic Arthritis NCT05223049 | Bezmialem Vakif University | — |
| Completed | A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic NCT05153148 | Takeda | Phase 2 |
| Recruiting | Psorcast Mobile Study NCT05621369 | Sage Bionetworks | — |
| Completed | A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis NCT05195814 | Pfizer | — |
| Completed | COVID-19 VaccinE Response in Rheumatology Patients NCT05080218 | Jeffrey Curtis | Phase 4 |
| Completed | Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 NCT05115370 | University of Nottingham | — |
| Completed | Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis NCT05055934 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Phase 2 |
| Withdrawn | Do Nanobubbles Improve Joint Hypoxia? NCT04844008 | University of Oxford | N/A |
| Completed | Prospective Longitudinal Effects of Intra-articular Corticosteroid Injection on Synovial Fluid Oxygen NCT04804449 | University of Oxford | — |
| Recruiting | Biobank for Inflammatory Chronic Diseases and Osteoporosis NCT05039216 | University Hospital, Toulouse | — |
| Unknown | To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis NCT04957550 | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| Completed | Improved Cardiovascular Health for Patients With Inflammatory Joint Diseases NCT04922840 | Diakonhjemmet Hospital | N/A |
| Unknown | Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging NCT05135312 | OptiSkin Medical | Phase 4 |
| Active Not Recruiting | A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Act NCT04908189 | Bristol-Myers Squibb | Phase 3 |
| Unknown | An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients NCT04967950 | Peking Union Medical College Hospital | Phase 1 |
| Active Not Recruiting | A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Act NCT04908202 | Bristol-Myers Squibb | Phase 3 |
| Completed | AsseSSing Impact in pSoriatic Treatment NCT05171270 | University of Oxford | — |
| Unknown | Axial Involvement in Psoriatic Arthritis Cohort NCT04434885 | Charite University, Berlin, Germany | — |
| Completed | Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo. NCT04711902 | Novartis Pharmaceuticals | Phase 3 |
| Terminated | Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal Ul NCT04857476 | The Royal Wolverhampton Hospitals NHS Trust | N/A |
| Completed | Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artifi NCT05677542 | Novartis Pharmaceuticals | — |
| Completed | Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice NCT04517669 | Pfizer | — |
| Active Not Recruiting | Tapering of Biologics in Inflammatory Arthritis Patients in Remission NCT04429776 | University of Manchester | N/A |
| Completed | Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis NCT05046431 | Bio-Thera Solutions | Phase 3 |
| Withdrawn | PsA T2T Statin Trial on Carotid and Coronary Atherosclerosis NCT04176978 | Chinese University of Hong Kong | N/A |
| Withdrawn | SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE NCT04417114 | Brigham and Women's Hospital | Phase 4 |
| Completed | The Diagnostic Ultrasound Enthesitis Tool (DUET) Study NCT04587362 | Women's College Hospital | — |
| Completed | Diet Interventions in Psoriatic Arthritis NCT04180904 | University of Pennsylvania | N/A |
| Terminated | COVID-19 Vaccination in Rheumatic Disease Patients NCT04839315 | Mayo Clinic | EARLY_Phase 1 |
| Active Not Recruiting | Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication NCT04798625 | Diakonhjemmet Hospital | — |
| Completed | A Study to Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Table NCT04758117 | AbbVie | — |
| Unknown | Arthroscopic Synovectomy of the Wrist in Inflammatory Arthritis NCT04755127 | Maasstad Hospital | N/A |
| Completed | Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' Na NCT04709354 | Bezmialem Vakif University | — |
| Completed | Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα- NCT04632927 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Monitoring Spondyloarthritis With SpA-Net NCT04673825 | Maastricht University Medical Center | N/A |
| Completed | Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseas NCT04655612 | University Hospital, Montpellier | — |
| Completed | The MEDIPSA Clinical Trial NCT04588623 | Medical University of Graz | N/A |
| Completed | Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients NCT04645420 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Completed | IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT NCT04347798 | University of Alberta | — |
| Unknown | Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic NCT04610476 | University of Erlangen-Nürnberg Medical School | Phase 3 |
| Completed | The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata NCT04239521 | Momentum Data | — |
| Completed | A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeu NCT05051943 | Fresenius Kabi | — |
| Unknown | Impact of Hyperuricemia on Psoriatic Arthritis NCT06125444 | University Hospital, Strasbourg, France | — |
| Recruiting | Rheumatology Patient Registry and Biorepository NCT04402086 | Yale University | — |
| Unknown | Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial In NCT04062695 | Charite University, Berlin, Germany | Phase 2 |
| Completed | Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With NCT04433442 | AbbVie | — |
| Completed | A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthriti NCT04713072 | ACELYRIN Inc. | Phase 2 |
| Withdrawn | Enhanced Clinics for Patients Diagnosed With Ankylosing Spondylitis and Psoriatic Arthritis NCT04341233 | NHS Lothian | — |
| Recruiting | Deployment o the Multidisciplinary Prospective Cohort Imminent NCT04334031 | University Hospital, Lille | N/A |
| Recruiting | Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatol NCT04800289 | Centre Hospitalier le Mans | — |
| Completed | Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Pati NCT04428502 | Pfizer | — |
| Unknown | Information and Acceptability of Biosimilars NCT04321291 | University Hospital, Montpellier | N/A |
| Withdrawn | Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apre NCT04102449 | Medical University of Graz | Phase 4 |
| Completed | A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) NCT04163016 | UCB Biopharma SRL | Phase 1 |
| Completed | Survey of Cannabis Use in Patients With Chronic Inflammatory Arthritis NCT04402554 | University Hospital, Clermont-Ferrand | — |
| Completed | PsA Secukinumab XCT Structural Progression Study NCT03623867 | Chinese University of Hong Kong | Phase 4 |
| Terminated | COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases NCT04335747 | Salome Kristensen | — |
| Completed | Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of NCT04345159 | Fondation Ophtalmologique Adolphe de Rothschild | — |
| Unknown | Evaluation of the Role of Inflammatory and Structural Ultrasound Abnormalities by Explaining the Perspective o NCT04325724 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Comparison of the Effectiveness of Functional Training Versus Resistance Exercises in Patients With Psoriatic NCT04304326 | Federal University of São Paulo | N/A |
| Completed | Evaluating of New Screening Tool for Arthritis* in Psoriasis NCT04277832 | Bezmialem Vakif University | — |
| Recruiting | APACHE Cohort (A Psoriatic Arthritis CoHort) NCT03768271 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjec NCT04209205 | Novartis Pharmaceuticals | Phase 3 |
| Completed | TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) Study NCT04261010 | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | N/A |
| Unknown | Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory D NCT04200690 | University of Aarhus | N/A |
| Enrolling By Invitation | GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, Sweden NCT04190758 | Vastra Gotaland Region | — |
| Recruiting | Evolution and Treatments of Chronic Inflammatory Systemic Diseases NCT04191395 | Centre Hospitalier Universitaire de Besancon | — |
| Terminated | Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Ar NCT04115748 | Gilead Sciences | Phase 3 |
| Terminated | Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Ha NCT04115839 | Gilead Sciences | Phase 3 |
| Completed | Impact of Decision-Framing in Psoriasis NCT04136314 | University of Southern California | N/A |
| Active Not Recruiting | Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK) NCT04602091 | Societe Francaise de Rhumatologie | — |
| Unknown | Optimization of Psoriatic and Seronegative Rheumatoid Arthritis Patients Selection and Treatment Outcomes of B NCT05767814 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Completed | Comparison of Hand Functions and Wrist Proprioception in Patients With and Without Psoriatic Arthritis NCT04553302 | Melissa Köprülüoğlu | — |
| Completed | Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects NCT04152759 | Bio-Thera Solutions | Phase 1 |
| Unknown | Impact of Barriers and Facilitators to Physical Activity in Patients With Inflammatory Arthritis NCT04426747 | Groupe Hospitalier Pitie-Salpetriere | — |
| Suspended | Yoga-mindfulness for Pain Management in Inflammatory Arthritis NCT04065958 | Karolinska Institutet | N/A |
| Completed | A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Su NCT04109976 | UCB Biopharma SRL | Phase 3 |
| Active Not Recruiting | A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects NCT04009499 | UCB Biopharma SRL | Phase 3 |
| Recruiting | Psoriatic Arthritis D2P Screening NCT04110522 | Jessica Walsh | N/A |
| Recruiting | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorde NCT03816345 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS NCT04018599 | Fresenius Kabi SwissBioSim GmbH | Phase 1 |
| Completed | Follow-up Evaluating Clinical and Radiological Outcomes of Total Shoulder Arthroplasty With Permedica's MIRAI NCT05128500 | Permedica spa | — |
| Completed | Effect of Custom Foot Orthoses in Patients With Psoriatic Arthritis NCT05075343 | Patrick Boissy | N/A |
| Completed | A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Regi NCT05413044 | Bristol-Myers Squibb | — |
| Completed | A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis NCT03963401 | Pfizer | Phase 2 |
| Completed | Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral NCT03816917 | Radboud University Medical Center | — |
| Unknown | Survivorship and Patient Outcomes of Primary Total Hip Arthroplasty With the Ovation Hip System NCT03986918 | Ortho Development Corporation | — |
| Completed | Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis NCT03926195 | Galapagos NV | Phase 2 |
| Completed | Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial NCT03739853 | University of Oxford | Phase 4 |
| Completed | PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis NCT03486613 | Salome Kristensen | N/A |
| Completed | Psoriatic Oligoarthritis Intervention With Symptomatic thErapy NCT03797872 | University of Oxford | Phase 4 |
| Completed | The Effect of Psoriatic Arthritis on the Functions of the Hand NCT04540809 | Inonu University | — |
| Unknown | Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in Greece NCT03780504 | Genesis Pharma S.A. | — |
| Completed | Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin Levels NCT03932110 | Istanbul Medeniyet University | N/A |
| Completed | A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arth NCT03895203 | UCB Biopharma SRL | Phase 3 |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic NCT03896581 | UCB Biopharma SRL | Phase 3 |
| Active Not Recruiting | A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a His NCT03675308 | AbbVie | Phase 3 |
| Completed | Carpal Tunnel Syndrome in Patients With Psoriatic Arthritis NCT05086029 | Selcuk University | — |
| Unknown | EBIO - Enthesitis Biopsy Study NCT04887597 | University of Erlangen-Nürnberg Medical School | Phase 4 |
| Completed | Carpal Tunnel Syndrome in Patients With Psoriatic Arthritis; Ultrasonography and Magnetic Resonance Imaging Fi NCT05086042 | Selcuk University | — |
| Terminated | Changes in Body Composition Under Ustekinumab in PsA NCT03823924 | University Hospital, Lille | — |
| Unknown | Therapeutic Strategy Associated With bDMARDs or tsDMARDs in Rheumatoid Arthritis and Psoriatic Arthritis NCT05082805 | Nordic Pharma SAS | — |
| Completed | Ultrasound Enthesitis Response in Psoriatic Arthritis NCT03955861 | Belfast Health and Social Care Trust | — |
| Completed | A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psori NCT03783026 | Amgen | Phase 4 |
| Completed | The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort St NCT03835780 | Momentum Data | — |
| Completed | Treatment Goals in Psoriatic Arthritis NCT03620188 | Johns Hopkins University | — |
| Unknown | Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP) NCT04515732 | Professor Mikkel Østergaard | Phase 4 |
| Completed | Psoriatic Arthritis and Psoriasis Treatment Decision Aid NCT03737045 | University of Pennsylvania | N/A |
| Completed | CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis. NCT03693833 | Aalborg University Hospital | Phase 2 |
| Completed | microRNA in Erosive Hand Osteoarthritis and Psoriatic Arthritis NCT05683769 | University of Siena | — |
| Completed | Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis NCT03486457 | Pfizer | Phase 3 |
| Completed | Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis NCT03598751 | Biocad | Phase 3 |
| Completed | Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS) NCT03419650 | IRIS Research and Development, LLC | Phase 4 |
| Completed | Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have P NCT03552276 | Sun Pharmaceutical Industries Limited | Phase 2 / Phase 3 |
| Active Not Recruiting | Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System NCT03626038 | Zimmer Biomet | N/A |
| Completed | Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis NCT03531073 | University of Oxford | — |
| Unknown | Early Biomarkers for ARthritic PAIN to Guide Improved Treatments for Arthritis NCT03533569 | St George's, University of London | — |
| Unknown | Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents NCT03470688 | Opal Rheumatology Ltd. | — |
| Completed | A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy an NCT03410992 | UCB Biopharma SRL | Phase 3 |
| Terminated | Mindfulness Based Stress Reduction in Rheumatic Diseases NCT03411057 | Johns Hopkins University | — |
| Completed | A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients NCT03402087 | Bristol-Myers Squibb | Phase 1 |
| Completed | Psoriatic Arthritis Research Collaborative: Biologic Sub-Study NCT03378336 | University of Pennsylvania | — |
| Completed | Patterns After Administration of MCFAs in Psoriasis and Psoriatic Arthritis NCT03409211 | NYU Langone Health | N/A |
| Completed | A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adu NCT03370133 | UCB Biopharma SRL | Phase 3 |
| Completed | A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis NCT03347110 | UCB Biopharma SRL | Phase 2 |
| Completed | Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in C NCT03223012 | AbbVie | — |
| Completed | Sonographic Analysis of Nails in Psoriatic Arthritis and Healthy Controls NCT04718428 | Marmara University | — |
| Completed | Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis NCT03736161 | Globe Pharmaceuticals Limited | Phase 3 |
| Completed | Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases NCT03248518 | University of Aberdeen | N/A |
| Completed | A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis NCT03151551 | Eli Lilly and Company | Phase 4 |
| Recruiting | Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons NCT03248284 | Odense University Hospital | — |
| Terminated | An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis. NCT03320876 | Galapagos NV | Phase 2 |
| Unknown | Pharmacist CVD Intervention for Patients With Inflammatory Arthritis NCT03152396 | Epidemiology Coordinating and Research Centre, Canada | N/A |
| Completed | Immune Metabolic Associations in Psoriatic Arthritis NCT03399708 | NHS Greater Glasgow and Clyde | — |
| Completed | Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective. NCT03119805 | Groupe Hospitalier Pitie-Salpetriere | — |
| Completed | Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis NCT03058900 | Odense University Hospital | N/A |
| Completed | A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a NCT03104374 | AbbVie | Phase 3 |
| Completed | A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis NCT03104400 | AbbVie | Phase 3 |
| Completed | A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is NCT03336281 | Janssen Cilag S.A.S. | — |
| Completed | Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis NCT02745080 | Novartis Pharmaceuticals | Phase 3 |
| Completed | A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis NCT03101670 | Galapagos NV | Phase 2 |
| Completed | The Norwegian Drug Monitoring Study NCT03074656 | Diakonhjemmet Hospital | N/A |
| Completed | DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA NCT03011242 | University of Rochester | — |
| Completed | A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spon NCT02988674 | AbbVie | — |
| Completed | Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active P NCT03148860 | Dr. Frank Behrens | Phase 3 |
| Completed | A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Vis NCT02986373 | AbbVie | Phase 2 |
| Completed | National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life NCT02925338 | Pfizer | — |
| Completed | Effect of Secukinumab in the Treatment of Psoriatic Arthritis NCT02854163 | University of Liverpool | Phase 2 |
| Completed | A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subject NCT02969525 | UCB Biopharma S.P.R.L. | Phase 2 |
| Completed | CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis NCT03953378 | Hospices Civils de Lyon | — |
| Completed | Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With A NCT02771210 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active NCT02662985 | Novartis Pharmaceuticals | Phase 3 |
| Completed | A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compa NCT02814175 | AbbVie | Phase 4 |
| Completed | A Phase 4 Clinical Study of Brodalumab NCT04183881 | Kyowa Kirin Co., Ltd. | Phase 4 |
| Terminated | Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis NCT02841176 | Imperial College Healthcare NHS Trust | N/A |
| Completed | Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psori NCT02798211 | Novartis Pharmaceuticals | Phase 4 |
| Completed | Korean Post-marketing Surveillance for Xeljanz NCT02984020 | Pfizer | — |
| Completed | Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) NCT02538341 | University of Alabama at Birmingham | Phase 2 |
| Completed | Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on P NCT02750800 | AbbVie | — |
| Withdrawn | Treatment With Apremilast in Patients With Psoriatic Arthritis NCT02558361 | University of South Florida | Phase 4 |
| Completed | Effects of Weight-loss Treatment in Obese Patients With Psoriatic Arthritis NCT02917434 | Vastra Gotaland Region | N/A |
| Completed | Frequency of Elevated Fecal Calprotectin Levels in Psoriatic Arthritis. NCT04190108 | Hospital of Prato | — |
| Completed | A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psor NCT02627768 | Janssen Pharmaceutica N.V., Belgium | — |
| Completed | GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA NCT04108468 | The Leeds Teaching Hospitals NHS Trust | Phase 3 |
| Terminated | A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Wh NCT02429895 | AbbVie | Phase 2 |
| Completed | A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthriti NCT02584855 | Eli Lilly and Company | Phase 3 |
| Completed | Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve NCT02605642 | Pfizer | — |
| Unknown | Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis NCT02572700 | Frederiksberg University Hospital | — |
| Completed | Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Pat NCT02556034 | Isabelle Fortin | — |
| Completed | Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 NCT02404350 | Novartis Pharmaceuticals | Phase 3 |
| Withdrawn | Pregnancy and Medically Assisted Conception in Rare Diseases NCT02450396 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Psoriasis-Arthritis & Bone Program NCT02483234 | University of Erlangen-Nürnberg Medical School | Phase 2 |
| Withdrawn | Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study NCT02472717 | University Health Network, Toronto | Phase 2 |
| Unknown | Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Dis NCT03214263 | Rigshospitalet, Denmark | — |
| Terminated | Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patie NCT03454932 | Bone Therapeutics S.A | — |
| Completed | Identification of New Prognostic Markers in Psoriatic Arthritis NCT03455166 | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | N/A |
| Withdrawn | Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis NCT02475304 | Skane University Hospital | Phase 2 |
| Completed | A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoria NCT02349451 | AbbVie | Phase 2 |
| Completed | DC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsA NCT02413749 | University of Rochester | — |
| Completed | Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment NCT02414633 | AbbVie | — |
| Unknown | PatientSpot Formerly Known as ArthritisPower NCT03840928 | Global Healthy Living Foundation | — |
| Completed | Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA) NCT02319759 | Janssen Research & Development, LLC | Phase 2 |
| Completed | A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine T NCT02486302 | Pfizer | — |
| Completed | Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis NCT02376790 | Amgen | Phase 3 |
| Completed | A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics NCT02470481 | Janssen Research & Development, LLC | — |
| Completed | PBR28 PET and Inflammatory Arthritis NCT02361385 | University of Oxford | — |
| Completed | A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis NCT02267642 | AbGenomics B.V Taiwan Branch | Phase 2 |
| Completed | A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis NCT02349295 | Eli Lilly and Company | Phase 3 |
| Active Not Recruiting | Apremilast Pregnancy Exposure Registry NCT02775500 | University of California, San Diego | — |
| Completed | Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous Psoriasis NCT03374527 | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | — |
| Completed | The NOR-SWITCH Study NCT02148640 | Diakonhjemmet Hospital | Phase 4 |
| Completed | A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating NCT02154425 | UCB BIOSCIENCES, Inc. | Phase 1 |
| Completed | Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, NCT02065713 | Instituto de Medicina Molecular João Lobo Antunes | Phase 3 |
| Completed | Evaluation of the Effectiveness of Resistance Training in Patients With Psoriatic Arthritis NCT02598739 | Federal University of São Paulo | N/A |
| Completed | Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis NCT02141763 | UCB Celltech | Phase 1 |
| Completed | 24 Week Efficacy and 3-year Safety and Efficacy of Secukinumab in Active Psoriatic Arthritis NCT01989468 | Novartis Pharmaceuticals | Phase 3 |
| Completed | Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune NCT04582084 | AryoGen Pharmed Co. | — |
| Completed | Vascular Effects of Achieving Minimal Disease Activity in Psoriatic Arthritis - a 2 Year Prospective Cohort St NCT02232321 | Chinese University of Hong Kong | N/A |
| Completed | Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis NCT02024646 | Bausch Health Americas, Inc. | Phase 3 |
| Terminated | Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arth NCT02029495 | Bausch Health Americas, Inc. | Phase 3 |
| Completed | A Phase 3 Clinical Study of KHK 4827 NCT02052609 | Kyowa Kirin Co., Ltd. | Phase 3 |